Central America vs Egypt: Proportion of the target population who received
Central America
73.0%
in 2024
Egypt
96.0%
in 2024
Central America rank
24th
Egypt rank
27th
Proportion of the target population who received over time
- Central America
- Egypt
How they compare
Egypt currently reports 96.0% against 73.0% in Central America, a difference of 23.0%.
That makes Egypt's figure about 1.3 times Central America's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Egypt ahead.
Central America ranks 24th and Egypt ranks 27th of 37 groups.
Egypt has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central America | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 69.4% | 96.8% | 27.4% | Egypt |
| 2010s | 72.6% | 94.5% | 21.9% | Egypt |
| 2020s | 80.0% | 95.4% | 15.4% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Central America or Egypt?
- Egypt, at 96.0% against 73.0% in Central America as of 2024.
- What is the difference in proportion of the target population who received between Central America and Egypt?
- 23.0%, with Egypt ahead.
- How many years of comparable data are there for Central America and Egypt?
- 25 years are reported by both, from 2000 to 2024.
- How do Central America and Egypt rank globally for proportion of the target population who received?
- Central America ranks 24th and Egypt ranks 27th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.